Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HAVN Life Sciences C.HAVN

Alternate Symbol(s):  HAVLD

HAVN Life Sciences Inc is a biotechnology company engaged in the business of the research and development of psycho-pharmacological products, including the formulation of standardized psychoactive compounds derived from fungi. The products of the company will help to improve mental health and human performance.


Recent & Breaking News (CSE:HAVN)

CSE Bulletin: Reinstatement - HAVN Life Sciences Inc. (HAVN)

Newsfile 2 days ago

IIROC Trade Resumption - HAVN

Canada NewsWire 3 days ago

CSE Bulletin: Suspension - HAVN Life Sciences Inc. (HAVN)

Newsfile January 9, 2023

IIROC Trading Halt - HAVN

Canada NewsWire January 9, 2023

HAVN Life Sciences (CSE:HAVN) announces retail listing with Loblaw (TSX:L)

Trevor Abes  October 31, 2022

HAVN Life Announces Retail Listing With Loblaws Company Ltd.

Canada NewsWire October 27, 2022

IIROC Trade Resumption - HAVN

Canada NewsWire September 20, 2022

HAVN Life Provides Corporate Update

Canada NewsWire September 20, 2022

IIROC Trading Halt - HAVN

Canada NewsWire September 19, 2022

HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments‎ and the Issuance of Shares for Debt

Canada NewsWire August 18, 2022

IIROC Trade Resumption - HAVN

Canada NewsWire August 3, 2022

IIROC Trading Halt - HAVN

Canada NewsWire August 3, 2022

CSE Bulletin: Consolidation - HAVN Life Sciences Inc. (HAVN)

Newsfile August 2, 2022

HAVN Life Announces a 30:1 Consolidation of its Common Shares

GlobeNewswire July 29, 2022

HAVN Life Sciences (CSE:HAVN) to supply psilocybin products for medical psilocybin & data project

Dave Jackson July 28, 2022

HAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of Convertible Debentures and Warrants

Canada NewsWire July 21, 2022

HAVN Life Enters Supply Agreement with MPB Group Inc.

Canada NewsWire June 28, 2022

HAVN Life To Be Featured On Viewpoint with Dennis Quaid

PR Newswire June 22, 2022

HAVN Life Announces Changes to the Board of Directors

Canada NewsWire June 14, 2022

HAVN Life Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals Ltd.

Canada NewsWire June 7, 2022